Creative Reconciled Depreciation from 2010 to 2024

CELZ Stock  USD 2.69  0.11  4.26%   
Creative Medical Reconciled Depreciation yearly trend continues to be fairly stable with very little volatility. Reconciled Depreciation will likely drop to about 64 K in 2024. During the period from 2010 to 2024, Creative Medical Reconciled Depreciation regression line of annual values had r-squared of  0.67 and arithmetic mean of  39,793. View All Fundamentals
 
Reconciled Depreciation  
First Reported
2016-06-30
Previous Quarter
29.3 K
Current Value
29.3 K
Quarterly Volatility
9.6 K
 
Covid
Check Creative Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Creative Medical's main balance sheet or income statement drivers, such as Selling General Administrative of 3.2 M, Other Operating Expenses of 5.9 M or Total Operating Expenses of 5.8 M, as well as many indicators such as Price To Sales Ratio of 757, Dividend Yield of 0.0039 or PTB Ratio of 0.66. Creative financial statements analysis is a perfect complement when working with Creative Medical Valuation or Volatility modules.
  
Check out the analysis of Creative Medical Correlation against competitors.

Latest Creative Medical's Reconciled Depreciation Growth Pattern

Below is the plot of the Reconciled Depreciation of Creative Medical Technology over the last few years. It is Creative Medical's Reconciled Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Creative Medical's overall financial position and show how it may be relating to other accounts over time.
Reconciled Depreciation10 Years Trend
Slightly volatile
   Reconciled Depreciation   
       Timeline  

Creative Reconciled Depreciation Regression Statistics

Arithmetic Mean39,793
Geometric Mean29,159
Coefficient Of Variation85.47
Mean Deviation29,583
Median15,995
Standard Deviation34,012
Sample Variance1.2B
Range89.9K
R-Value0.82
Mean Square Error414.5M
R-Squared0.67
Significance0.0002
Slope6,213
Total Sum of Squares16.2B

Creative Reconciled Depreciation History

202464 K
2023105.9 K
202192.1 K
202066.8 K
201926.9 K
201821.1 K

About Creative Medical Financial Statements

Creative Medical investors use historical fundamental indicators, such as Creative Medical's Reconciled Depreciation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Creative Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Reconciled Depreciation105.9 K64 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Creative Stock Analysis

When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.